{"nct_id":"NCT01912872","title":"Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma","status":"TERMINATED","status_verified_date":"2019-06","start_date":"2013-11-11","start_date_type":"ACTUAL","primary_completion_date":"2015-08-06","primary_completion_date_type":"ACTUAL","completion_date":"2016-01-08","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["NVS"]}